Biotechnology company Sanaria has announced the launch of a suite of products intended to advance research towards new malaria vaccines, drugs, and diagnostics, and enhanced understanding of malaria pathology and immunobiology. Sanaria’s mission is to develop and commercialize wholeparasite malaria vaccines that confer high-level, long-lasting protection against malaria caused by … [Read more...]
Sanaria Wins $3M Grant for Development of Malaria Vaccine
Sanaria has won a three-year, $3 million phase 2 Small Business Research Innovation grant from the National Institutes of Health to further develop its malaria vaccine. The money will support research by scientists at the Rockville company and its partner, Columbia University, according to Sanaria information. The new grant continues earlier NIH-supported efforts at Sanaria and Columbia to … [Read more...]